Significant differences in pathways related to cancer progression, such as the ERBB signaling pathway and VEGF signaling pathway, and pathways associated with the immune response, such as the B cell receptor signaling pathway and T cell receptor signaling pathway, were observed between the two clusters (Figure 3D). The gene discussed is EGFR; the disease is cancer.